https://www.prnewswire.com/news-releases/cadrenal-therapeutics-nasdaq-cvkd-announces-closing-of-initial-public-offering-301729619.html?tc=eml_cleartime
Cadrenal Therapeutics (Nasdaq: CVKD) Announces Closing of Initial Public Offering
/PRNewswire/ -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company focused on developing tecarfarin, a clinical-stage novel cardiorenal...
therapeuticsnasdaqannouncesclosinginitial